跳转至内容
Merck
所有图片(2)

主要文件

HCYP2MAG-62K

Millipore

MILLIPLEX® 人细胞因子/趋化因子磁珠板II - 免疫学多重分析

Simultaneously analyze multiple cytokine and chemokine biomarkers with Bead-Based Multiplex Assays using the Luminex technology, in human serum, plasma and cell culture samples.

别名:

Human cytokine multiplex kit, Luminex® human cytokine immunoassay, Millipore human cytokine panel

登录查看公司和协议定价


About This Item

分類程式碼代碼:
12161503
eCl@ss:
32161000
NACRES:
NA.84

品質等級

物種活性

human

製造商/商標名

Milliplex®

assay range

accuracy: 81-110%
sensitivity: 0.4-55.8 pg/mL
standard curve range: 1.0-100,000 pg/mL

技術

multiplexing: suitable

檢測方法

fluorometric (Luminex xMAP)

運輸包裝

wet ice

一般說明

“细胞因子”是用于多种可溶性蛋白质和肽的通用术语,其在正常和病理条件下充当调节剂以调节单个细胞和组织的功能活性。这些蛋白质还介导细胞之间的直接各种相互作用并调节细胞外环境中发生的过程。细胞因子组蛋白包括淋巴因子、干扰素、集落刺激因子和趋化因子。细胞因子和趋化因子研究对于更深入地了解免疫系统及其对大多数抗原的多方面反应以及疾病状态(例如炎症性疾病,过敏反应,肠易激综合征(IBD),脓毒症和癌症)具有重要作用。

MILLIPLEX®人细胞因子/趋化因子面板II使您能够专注于细胞因子的治疗潜力以及细胞因子表达的调节。

Luminex® xMAP®平台使用磁珠免疫分析格式,以实现理想的速度和灵敏度,同时定量多种分析物,从而显著提高生产力,同时节省宝贵的样本量。

面板类型:细胞因子/趋化因子

特異性

交叉反应性
对于该面板中的任何其他分析物,抗体之间没有或有可以忽略不计的交叉反应性。

應用

  • 分析物:6Ckine, BCA-1, CTACK, ENA-78, Eotaxin-2, Eotaxin-3, I-309, IL-16, IL-20, IL-21, IL-23, IL-28A, IL-33, LIF, MCP-2, MCP-4, MIP-1δ, SCF, SDF-1A+β, TARC, TPO, TRAIL, TSLP
  • 推荐的样品类型:血清,血浆和细胞培养上清液
  • 推荐的样品稀释度:未稀释
  • 分析运行时间:过夜或2小时初次孵育。为了获得最佳结果,建议过夜孵育
  • 研究类别:炎症 & 免疫学
  • 研究子类别:肥胖,代谢紊乱,炎症 & 自身免疫机制

特點和優勢

通过在此面板中选择可用的分析物来设计多重试剂盒。

包裝

96孔板

儲存和穩定性

试剂盒组分建议的存储温度为2-8°C。

其他說明

请联系技术服务部进行稀释度线性研究。

法律資訊

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

訊號詞

Danger

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

標靶器官

Respiratory Tract

儲存類別代碼

10 - Combustible liquids


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores.
Mansell, H; Rosaasen, N; Dean, J; Shoker, A
Clinical Transplantation null
Myung-Ho Kim et al.
medRxiv : the preprint server for health sciences (2021-03-25)
We analyzed the plasma levels of interferons and cytokines, and the expression of interferon-stimulated genes in peripheral blood mononuclear cells in COVID-19 patients with different disease severity. Mild patients exhibited transient type I interferon responses, while ICU patients had prolonged
Beatriz M Carreno et al.
The Journal of clinical investigation, 123(8), 3383-3394 (2013-07-23)
Systemic administration of IL-12p70 has demonstrated clinical activity in cancer patients, but dose-limiting toxicities have hindered its incorporation in vaccine formulations. Here, we report on the immunological and clinical outcomes upon vaccination with CD40L/IFN-γ-matured, IL-12p70-producing DCs. 7 HLA-A*0201+ newly diagnosed
Ashok Kumar Kumawat et al.
Mediators of inflammation, 2014, 879843-879843 (2014-10-22)
Soluble factors from intestinal mucosal cells contribute to immune homeostasis in the gut. We have established an in vitro model to investigate the regulatory role of soluble factors from inflamed intestinal mucosa of collagenous colitis (CC) patients in the differentiation
Olivia Estévez et al.
PloS one, 15(7), e0235859-e0235859 (2020-07-21)
In our work, we aim to identify new candidate host biomarkers to discriminate between active TB patients (n = 28), latent infection (LTBI; n = 27) and uninfected (NoTBI; n = 42) individuals. For that, active TB patients and their

相关内容

See how MILLIPLEX® multiplex immunoassays offer researchers the ability to simultaneously quantitate a large number of human cytokines, chemokines, and growth factors, and detect human immunoglobulins against SARS-CoV-2 antigens, to better understand the immune response to COVID-19, including cytokine storm.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门